Demystifying PBMs and Transparent Pharmacy Benefits
In this episode of The ASHHRA Podcast, our healthcare business development executives, Kinjal Patel and Brady Heiner, share actionable strategies to help hospitals and health systems address rising costs and unpack contract confusion.
Listen to learn more about:
- What transparency really means, and how to distinguish it from marketing hype.
- Strategies to manage high-cost specialty drugs.
- How to leverage your in-house hospital pharmacy to generate savings.
- Why an expert partner is critical for more strategic plan design.
We’re happy to connect with you or your benefits advisor to discuss how your organization can stay prepared in this ever-changing landscape.
You Might Also Enjoy
The Battle Over 340B Drug Pricing (Part 2)
The Battle Over 340B Drug Pricing (Part 2) Explore the complexities and upcoming changes to 340B with RxBenefits and the…
Why HR Leaders Should Care About 340B
Why HR Leaders Should Care About 340B As the second-largest federal drug program in the U.S., the 340B program plays…
